Correlation of pretransplant hyperglycemia and delayed graft function in kidney transplantation

Iranian Journal of Kidney Diseases

Volumn 4, Issue 2, 2010, Pages 147-152

  Hekmat, Reza ^a   Eshraghi, Hamid ^a  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Blood glucose; Delayed graft function; Kidney transplantation

Indexed keywords

CREATININE; GLUCOSE;

ACUTE GRAFT REJECTION; ACUTE KIDNEY TUBULE NECROSIS; ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; BODY MASS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DELAYED GRAFT FUNCTION; DIASTOLIC BLOOD PRESSURE; DISEASE COURSE; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GRAFT RECIPIENT; HEMODIALYSIS; HUMAN; HYPERGLYCEMIA; IMMUNOTHERAPY; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; KIDNEY BIOPSY; KIDNEY SCINTISCANNING; KIDNEY TRANSPLANTATION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; SYSTOLIC BLOOD PRESSURE;

ADOLESCENT; ADULT; DELAYED GRAFT FUNCTION; FEMALE; HUMANS; HYPERGLYCEMIA; KIDNEY TRANSPLANTATION; LOGISTIC MODELS; MALE; ODDS RATIO; YOUNG ADULT;

EID: 77953158463     PISSN: 17358582     EISSN: 17358604     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Disney APS, Russ GR, Walker R, et al. Australia and New Zealand dialysis and transplant registry. ANZDTA Registry Report; 1999.
2. Sirivongs D, Liawnoraset W, Pongskul C, Reungjui S. Graft survival analysis in kidney transplantation: a 12-year experience in a Thai medical center. Transplant Proc. 2004;36:2034-7.
3. Pourmand G, Ebrahimi MR, Mehrsai AR, Taheri M. Patient blood glucose levels before and after kidney transplantation. Transplant Proc. 2000;32:566-8.
4. Thomas MC, Mathew TH, Russ GR. Glycaemic control and graft loss following renal transplantation. Nephrol Dial Transplant. 2001;16:1978-82.
5. Boom H, Paul LC, de Fijter JW. Delayed graft function in renal transplantation. Transplant Rev. 2004;18:139-52.
6. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care. 2004;27:1487-95.
7. Guarnieri G, Zanetti M, Vinci P, Cattin MR, Barazzoni R. Insulin resistance in chronic uremia. J Ren Nutr. 2009;19:20-4.
8. Zanetti M, Barazzoni R, Guarnieri G. Inflammation and insulin resistance in uremia. J Ren Nutr. 2008;18:70-5.
9. Akmal M, Massry SG, Goldstein DA, Fanti P, Weisz A, DeFronzo RA. Role of parathyroid hormone in the glucose intolerance of chronic renal failure. J Clin Invest. 1985;75:1037-44.
10. Mak RH. Effect of metabolic acidosis on insulin action and secretion in uremia. Kidney Int. 1998;54:603-7.
11. Chan HW, Cheung CY, Liu YL, et al. Prevalence of abnormal glucose metabolism in Chinese renal transplant recipients: a single centre study. Nephrol Dial Transplant. 2008;23:3337-42.
12. Ganji MR, Charkhchian M, Hakemi M, et al. Association of hyperglycemia on allograft function in the early period after renal transplantation. Transplant Proc. 2007;39:852-4.
13. Brennan TV, Freise CE, Fuller TF, Bostrom A, Tomlanovich SJ, Feng S. Early graft function after living donor kidney transplantation predicts rejection but not outcomes. Am J Transplant. 2004;4:971-9.
14. van den Berg TJ, Bogers H, Vriesendorp TM, et al. No apparent impact of increased post-operative blood glucose levels on clinical outcome in kidney transplant recipients. Clin Transplant. 2009;23:256-63.
15. Podrazik RM, Natale JE, Zelenock GB, D'Alecy LG. Hyperglycemia exacerbates and insulin fails to protect in acute renal ischemia in the rat. J Surg Res. 1989;46:572-8.
16. Akbari CM, Saouaf R, Barnhill DF, Newman PA, LoGerfo FW, Veves A. Endothelium-dependent vasodilatation is impaired in both microcirculation and macrocirculation during acute hyperglycemia. J Vasc Surg. 1998;28:687-94.
17. Troppmann C, Gillingham KJ, Benedetti E, et al. Delayed graft function, acute rejection, and outcome after cadaver renal transplantation. The multivariate analysis. Transplantation. 1995;59:962-8.
18. Min C, Kang E, Yu SH, Shinn SH, Kim YS. Advanced glycation end products induce apoptosis and procoagulant activity in cultured human umbilical vein endothelial cells. Diabetes Res Clin Pract. 1999;46:197-202.
19. Goes N, Urmson J, Ramassar V, Halloran PF. Ischemic acute tubular necrosis induces an extensive local cytokine response. Evidence for induction of interferongamma, transforming growth factor-beta 1, granulocytemacrophage colony-stimulating factor, interleukin-2, and interleukin-10. Transplantation. 1995;59:565-72.
20. Rutault K, Alderman C, Chain BM, Katz DR. Reactive oxygen species activate human peripheral blood dendritic cells. Free Radic Biol Med. 1999;26:232-8.
21. Pavlovic D, van de Winkel M, van der Auwera B, et al. Effect of interferon-gamma and glucose on major histocompatibility complex class I and class II expression by pancreatic beta- and non-beta-cells. J Clin Endocrinol Metab. 1997;82:2329-36.
22. Daemen MA, van 't Veer C, Denecker G, et al. Inhibition of apoptosis induced by ischemia-reperfusion prevents inflammation. J Clin Invest. 1999;104:541-9.
23. Rovere P, Vallinoto C, Bondanza A, et al. Bystander apoptosis triggers dendritic cell maturation and antigenpresenting function. J Immunol. 1998;161:4467-71.
24. Panes J, Kurose I, Rodriguez-Vaca D, et al. Diabetes exacerbates inflammatory responses to ischemiareperfusion. Circulation. 1996;93:161-7.
25. Yerneni KK, Bai W, Khan BV, Medford RM, Natarajan R. Hyperglycemia-induced activation of nuclear transcription factor kappaB in vascular smooth muscle cells. Diabetes. 1999;48:855-64.
26. Takami S, Yamashita S, Kihara S, Kameda-Takemura K, Matsuzawa Y. High concentration of glucose induces the expression of intercellular adhesion molecule-1 in human umbilical vein endothelial cells. Atherosclerosis. 1998;138:35-41.
27. Rattan V, Shen Y, Sultana C, Kumar D, Kalra VK. Glucose-induced transmigration of monocytes is linked to phosphorylation of PECAM-1 in cultured endothelial cells. Am J Physiol. 1996;271:E711-7.
28. Manduteanu I, Voinea M, Serban G, Simionescu M. High glucose induces enhanced monocyte adhesion to valvular endothelial cells via a mechanism involving ICAM-1, VCAM-1 and CD18. Endothelium. 1999;6:315-24.
29. Reinhold D, Ansorge S, Schleicher ED. Elevated glucose levels stimulate transforming growth factorbeta 1 (TGF-beta 1), suppress interleukin IL-2, IL-6 and IL-10 production and DNA synthesis in peripheral blood mononuclear cells. Horm Metab Res. 1996;28:267-70.
30. Hanson LA, Padyukov L, Strandvik B, Wramner L. [The immune system of the hunter-gatherer meets poverty and excess]. Lakartidningen. 2000;97:1823-6. Swedish.
31. Fernandez-Real JM, Ricart W. Insulin resistance and inflammation in an evolutionary perspective: the contribution of cytokine genotype/phenotype to thriftiness. Diabetologia. 1999;42:1367-74.
32. Fadda GZ, Hajjar SM, Perna AF, Zhou XJ, Lipson LG, Massry SG. On the mechanism of impaired insulin secretion in chronic renal failure. J Clin Invest. 1991;87:255-61.
33. Hagen M, Hjelmesaeth J, Jenssen T, Morkrid L, Hartmann A. A 6-year prospective study on new onset diabetes mellitus, insulin release and insulin sensitivity in renal transplant recipients. Nephrol Dial Transplant. 2003;18:2154-9.
34. Nam JH, Mun JI, Kim SI, et al. beta-Cell dysfunction rather than insulin resistance is the main contributing factor for the development of postrenal transplantation diabetes mellitus. Transplantation. 2001;71:1417-23.